Join our email list to stay up to date on the latest Amyloidosis news.

I recently had the opportunity to attend this public meeting at the FDA to discuss the Patient Perspectives on the Impact of Rare Diseases. This meeting was held as opportunity to bring the voices of patients and caregivers to the table of the Agency (more…)

*

*

*









*